Lab Head, Walter and Eliza Hall Institute of Medical Research
Dr Marco Herold is a Laboratory Head in the Molecular Genetics of Cancer Division at the Walter and Eliza Hall Institute of Medical Research. He is an expert in developing novel mouse models, and has brought the CRISPR/Cas9 genome editing technology to WEHI, where he is also heading the CRISPR laboratory, whose task it is to generate genome modified mice.
Dr Herold’s PhD at the University of Würzburg (Germany) addressed key questions in apoptosis and cancer. After his PhD, Dr Herold moved into the field of mouse genetics and to date, has generated more than 15 different rodent models, facilitating research into diseases including cancer and type 2 diabetes. His major research interest is in the identification of novel genes in apoptosis and in finding new targets for cancer therapy.
Dr Herold will speak about the implementation of the CRISPR/Cas9 technology for genome manipulation in cells and mice, and how it is used as a screening tool for the identification of new cell death regulators.